Valuation Gilead Sciences, Inc. Mexican S.E.

Stocks

End-of-day quote Mexican S.E. Other stock markets 10/06/2026			5-day change	1st Jan Change
2,117.15 ^MXN	-6.44%		0.00%	-4.73%

06-17	Gilead Sciences Insider Sold Shares Worth $376,200, According to a Recent SEC Filing	MT
06-16	Warsh Takes the Stage

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	91,081	107,677	100,942	115,118	152,281	153,657	-	-
Change	-	18.22%	-6.25%	14.04%	32.28%	0.9%	-	-
Enterprise Value (EV) ¹	118,530	126,522	118,665	131,838	169,585	163,225	153,560	143,250
Change	-	6.74%	-6.21%	11.1%	28.63%	-3.75%	-5.92%	-6.71%
P/E	14.7x	23.6x	18x	243x	18.1x	-44.3x	16.1x	14.7x
PBR	4.32x	5.05x	4.48x	5.98x	6.73x	8.41x	6.51x	5.17x
PEG	-	-0.9x	0.8x	-2.7x	0x	0x	-0x	1.61x
Capitalization / Revenue	3.34x	3.95x	3.72x	4x	5.17x	5.04x	4.74x	4.49x
EV / Revenue	4.34x	4.64x	4.38x	4.59x	5.76x	5.36x	4.73x	4.19x
EV / EBITDA	8.12x	8.86x	9.01x	11.7x	10.6x	29.5x	8.45x	7.49x
EV / EBIT	9.45x	10.4x	11.3x	15.5x	12.9x	59.6x	9.88x	8.61x
EV / FCF	11x	15.2x	16x	12.8x	17.9x	160x	11.6x	10.3x
FCF Yield	9.12%	6.59%	6.25%	7.82%	5.58%	0.62%	8.62%	9.71%
Dividend per Share ²	2.84	2.92	3	3.08	3.16	3.246	3.316	2.959
Rate of return	3.91%	3.4%	3.7%	3.33%	2.57%	2.62%	2.68%	2.39%
EPS ²	4.93	3.64	4.5	0.38	6.78	-2.791	7.7	8.404
Distribution rate	57.6%	80.2%	66.7%	811%	46.6%	-116%	43.1%	35.2%
Net sales ¹	27,305	27,281	27,116	28,754	29,443	30,478	32,450	34,218
EBITDA ¹	14,598	14,283	13,177	11,287	15,953	5,525	18,175	19,128
EBIT ¹	12,548	12,180	10,484	8,520	13,193	2,738	15,538	16,633
Net income ¹	6,225	4,592	5,665	480	8,510	-3,373	9,603	10,404
Net Debt ¹	27,449	18,845	17,723	16,720	17,304	9,568	-96.43	-10,407
Reference price ²	72.61	85.85	81.01	92.37	122.74	123.76	123.76	123.76
Nbr of stocks (in thousands)	1,254,384	1,254,244	1,246,042	1,246,266	1,240,680	1,241,570	-	-
Announcement Date	2/1/22 A	2/2/23 A	2/6/24 A	2/11/25 A	2/10/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	32.01x	11.69x	23.99x	0.62%	980B
JOHNSON & JOHNSON	24.41x	5.63x	15.32x	2.34%	550B
ABBVIE INC.	26.86x	6.49x	13.28x	3.17%	382B
ROCHE HOLDING AG	17.04x	4.24x	10.43x	3.13%	316B
ASTRAZENECA PLC	21.94x	4.59x	13.02x	1.91%	272B
NOVARTIS AG	20.28x	5.27x	12.78x	3.05%	268B
NOVO NORDISK A/S	13x	4.83x	9.94x	3.87%	199B
AMGEN INC.	21.95x	5.91x	10.33x	2.99%	182B
PFIZER INC.	11.79x	3.11x	7.57x	6.95%	144B
Average	21.03x	5.75x	12.96x	3.11%	365.82B
Weighted average by Cap.	24.33x	7.14x	15.86x	2.35%